» Articles » PMID: 32935263

From Microbiota Toward Gastro-enteropancreatic Neuroendocrine Neoplasms: Are We on the Highway to Hell?

Abstract

Gut microbiota is represented by different microorganisms that colonize the intestinal tract, mostly the large intestine, such as bacteria, fungi, archaea and viruses. The gut microbial balance has a key role in several functions. It modulates the host's metabolism, maintains the gut barrier integrity, participates in the xenobiotics and drug metabolism, and acts as protection against gastro-intestinal pathogens through the host's immune system modulation. The impaired gut microbiota, called dysbiosis, may be the result of an imbalance in this equilibrium and is linked with different diseases, including cancer. While most of the studies have focused on the association between microbiota and gastrointestinal adenocarcinomas, very little is known about gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs). In this review, we provide an overview concerning the complex interplay between gut microbiota and GEP NENs, focusing on the potential role in tumorigenesis and progression in these tumors.

Citing Articles

Butyrate Ameliorates Graves' Orbitopathy Through Regulating Orbital Fibroblast Phenotypes and Gut Microbiota.

Ouyang P, Qi J, Tong B, Li Y, Cao J, Wang L Invest Ophthalmol Vis Sci. 2025; 66(3):5.

PMID: 40035727 PMC: 11892527. DOI: 10.1167/iovs.66.3.5.


Impact of dyslipidemia and lipid-lowering therapy with statins in patients with neuroendocrine tumors.

Faggiano A, Russo F, Zamponi V, Sesti F, Puliani G, Modica R J Neuroendocrinol. 2024; 37(2):e13485.

PMID: 39726194 PMC: 11791004. DOI: 10.1111/jne.13485.


Insights into the Two Most Common Cancers of Primitive Gut-Derived Structures and Their Microbial Connections.

Ray A, Moore T, Naik D, Borsch D Medicina (Kaunas). 2024; 60(9).

PMID: 39336556 PMC: 11434611. DOI: 10.3390/medicina60091515.


Identification of TIMP1-induced dysregulation of epithelial-mesenchymal transition as a key pathway in inflammatory bowel disease and small intestinal neuroendocrine tumors shared pathogenesis.

Tran M Front Genet. 2024; 15:1376123.

PMID: 39233736 PMC: 11371700. DOI: 10.3389/fgene.2024.1376123.


Investigating the causal relationship between gut microbiota and gastroenteropancreatic neuroendocrine neoplasms: a bidirectional Mendelian randomization study.

Zhang C, Jiang S, Cao J, Xu Y, Wang X, Li R Front Microbiol. 2024; 15:1420167.

PMID: 39193433 PMC: 11347282. DOI: 10.3389/fmicb.2024.1420167.


References
1.
Roland C, Starker L, Kang Y, Chatterjee D, Estrella J, Rashid A . Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection. Surgery. 2016; 161(3):753-759. PMC: 5937257. DOI: 10.1016/j.surg.2016.09.002. View

2.
Doerffel Y, Pavel M, Loening-Baucke V, Swidsinski A . Common biostructure of the fecal flora in celiac disease, Crohn's disease, and carcinoid tumors. Inflamm Bowel Dis. 2008; 14(11):1613-4. DOI: 10.1002/ibd.20507. View

3.
Zhao Y, Aguilar A, Bernard D, Wang S . Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment. J Med Chem. 2014; 58(3):1038-52. PMC: 4329994. DOI: 10.1021/jm501092z. View

4.
Ning L, Chen H, Kunnimalaiyaan M . Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cells. Mol Cancer Res. 2010; 8(5):775-82. PMC: 2872724. DOI: 10.1158/1541-7786.MCR-09-0525. View

5.
Sokol H, Leducq V, Aschard H, Pham H, Jegou S, Landman C . Fungal microbiota dysbiosis in IBD. Gut. 2016; 66(6):1039-1048. PMC: 5532459. DOI: 10.1136/gutjnl-2015-310746. View